Clinical outcomes of patients with chemo-refractory pancreatic adenocarcinoma participating in phase I clinical trials

被引：0
|
作者：
Sasaki, M. [1 ]
Satake, T. [1 ]
Watanabe, K. [1 ]
Imaoka, H. [1 ]
Shibuki, T. [1 ]
Inoue, K. [1 ]
Taira, T. [1 ]
Igarashi, G. [1 ]
Yamaguchi, S. [1 ]
Mitsunaga, S. [1 ]
Ikeda, M. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
358P
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [21] Clinical Outcomes and Survival of Advanced Renal Cancer Patients in Phase I Clinical Trials
    Malik, Laeeq
    Parsons, Helen
    Mahalingam, Devalingam
    Ehler, Benjamin
    Goros, Martin
    Mejia, Alex
    Brenner, Andrew
    Sarantopoulos, John
    CLINICAL GENITOURINARY CANCER, 2014, 12 (05) : 359 - 365
  • [22] Randomized Clinical Trials in Pancreatic Adenocarcinoma
    Rudloff, Udo
    Maker, Ajay V.
    Brennan, Murray F.
    Allen, Peter J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (01) : 115 - +
  • [23] Clinical outcomes and prognostic factors in 83 patients with pancreatic cancer treated in phase I clinical trials at MD Anderson Cancer Center
    Tsimberidou, Apostolia M.
    Vaklavas, Christos
    Wen, Sijin
    Hong, David
    Wheler, Jennifer
    Ng, Chaan S.
    Naing, Aung
    Uehara, Cynthia
    Wolff, Robert
    Kurzrock, Razelle
    CANCER RESEARCH, 2010, 70
  • [24] Clinical outcomes and survival of advanced renal cancer patients in Phase I clinical trials.
    Malik, Laeeq
    Parsons, Helen
    Mahalingam, Devalingam
    Ehler, Benjamin
    Goros, Martin
    Brenner, Andrew
    Sarantopoulos, John
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [25] Survival and clinical outcomes of ovarian cancer patients enrolled in phase I clinical trials.
    Corr, Bradley
    Moroney, Marisa
    Sheeder, Jeanelle
    Sawyer, Brandon
    Eckhardt, S. Gail
    Behbakht, Kian
    Diamond, Jennifer Robinson
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Chemobrain in patients participating in clinical trials
    Trivanovic, D.
    Spasic, N.
    Plestina, S.
    Dobrila-Dintinjana, R.
    Jerin, L.
    Hrstic, I.
    Peharda, T.
    Honovic, L.
    Kocic, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S285 - S286
  • [27] Patients with pancreatic cancer participating in clinical trials - Are targets being met, and if not, why?
    Board, Ruth E.
    Thorley, Daniel
    Hawkins, Robert E.
    Valle, Juan W.
    PANCREAS, 2007, 34 (02) : 269 - 270
  • [28] Outcomes of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Included in Phase I Clinical Trials
    Brault, Marion
    Annereau, Maxime
    Danu, Alina
    Lazarovici, Julien
    Chahine, Claude
    Varga, Andrea
    Baldini, Capucine
    Champiat, Stephane
    Berhoune, Malik
    Massard, Christophe
    Lemare, Francois
    Ribrag, Vincent
    Michot, Jean-Marie
    BLOOD, 2018, 132
  • [29] Encouraging Clinical Outcomes for Lymphoma Patients Participating in Early Phase Clinical Trials in the Current Era: A Single Institution and a Global Perspective
    O'Nions, Jenny
    Cowley, Anna
    Dehbi, Hakim-Moulay
    El-Sharkawi, Dima
    D'Sa, Shirley
    Ardeshna, Kirit M.
    Popat, Rakesh
    Townsend, William
    BLOOD, 2018, 132
  • [30] Phase I clinical trials in patients ≥80
    Gaddipati, Himabindu
    Fu, Pingfu
    Dowlati, Afshin
    JOURNAL OF GERIATRIC ONCOLOGY, 2011, 2 (02) : 142 - 146
12345